In a collaboration between McMaster University and Stanford University, a team of researchers has unveiled a cutting-edge artificial intelligence (AI) model poised to revolutionize the discovery of antibiotics. Named SyntheMol, this innovative generative AI model boasts the unprecedented capability to design billions of novel antibiotic molecules, promising a potent arsenal against drug-resistant bacteria. The emergence